Aasld Liver Meeting 2025. At pr medical events we are delighted to extend our support. Click go to search above to select the sessions.

Carisma’s initial fibrosis program is focused on addressing liver fibrosis, a significant global health challenge. The designations are supported by compelling positive safety and efficacy data from the phase 2 solstice trial, from which the company recently presented new data at.